GARUFI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 557
EU - Europa 379
AS - Asia 244
SA - Sud America 10
AF - Africa 2
OC - Oceania 1
Totale 1.193
Nazione #
US - Stati Uniti d'America 553
SG - Singapore 104
IT - Italia 79
IE - Irlanda 78
CN - Cina 76
SE - Svezia 52
DE - Germania 44
UA - Ucraina 35
GB - Regno Unito 29
TR - Turchia 24
RU - Federazione Russa 17
VN - Vietnam 17
FR - Francia 11
BR - Brasile 10
FI - Finlandia 10
IN - India 7
AT - Austria 6
BE - Belgio 6
HK - Hong Kong 5
JP - Giappone 4
CA - Canada 3
IR - Iran 3
NL - Olanda 3
RO - Romania 3
NG - Nigeria 2
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CU - Cuba 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
Totale 1.193
Città #
Chandler 121
Singapore 85
Dublin 77
Jacksonville 66
Princeton 38
Ashburn 30
Ann Arbor 29
Southend 24
Santa Clara 23
Wilmington 21
Altamura 18
Dong Ket 17
Nanjing 17
Falls Church 13
Chieti 12
Izmir 12
Los Angeles 12
Nuremberg 11
Dearborn 10
Nanchang 10
Cambridge 9
Washington 7
Beijing 6
Brussels 6
Rome 6
Grafing 5
Hong Kong 5
Houston 5
Boardman 4
Moscow 4
New York 4
Isfahan 3
Kunming 3
Lappeenranta 3
Macerata 3
Tianjin 3
Buffalo 2
Changchun 2
Changsha 2
Edinburgh 2
Guangzhou 2
Hebei 2
Helsinki 2
L'aquila 2
Lagos 2
Menlo Park 2
Norwalk 2
Romola 2
Seattle 2
Shenyang 2
Tokyo 2
Adelaide 1
Almaty 1
Amsterdam 1
Andover 1
Araruama 1
Ariquemes 1
Armazém 1
Atlanta 1
Baku 1
Baoding 1
Benxi 1
Betim 1
Bologna 1
Bucharest 1
Burnaby 1
Chicago 1
Chisinau 1
Chongqing 1
Florence 1
Fuzhou 1
Guidonia 1
Hangzhou 1
Havana 1
Irsina 1
Jinan 1
Lanzhou 1
Las Vegas 1
Marechal Cândido Rondon 1
Marília 1
Minervino Murge 1
Minneapolis 1
Minsk 1
Ottawa 1
Paris 1
Parma 1
Pescara 1
Poços de Caldas 1
Qingdao 1
Ribeirão do Sul 1
Salerno 1
San Mateo 1
Santo André 1
Shanghai 1
Shenzhen 1
Sittard 1
Sopron 1
São Paulo 1
Tallinn 1
Tel Aviv 1
Totale 801
Nome #
Zn(II)-curc targets p53 in thyroid cancer cells 100
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies 96
Hyperglycemia triggers HIPK2 protein degradation 86
HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like 82
The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells 79
Reactivation of mutant p53 by capsaicin, the major constituent of peppers 79
ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose 69
P53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions 68
Clearing mutant p53 with natural compounds: implication for anticancer therapeutical approaches 68
Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences 65
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response 57
Interplay between endoplasmic reticulum (ER) stress and autophagy induces mutant p53H273 degradation 56
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 55
PBA preferentially impairs cell survival of glioblastomas carrying mutp53 by reducing its expression level, stabilizing wtp53, downregulating the mevalonate kinase and dysregulating UPR 52
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status 52
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study 38
Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity 33
P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex 33
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions 26
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study 23
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells 23
HIPK2 as a Novel Regulator of Fibrosis 21
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases 20
New Copper-Based Metallodrugs with Anti-Invasive Capacity 18
HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies 13
Pyrazolone-Based Zn(II) Complexes Display Antitumor Effects in Mutant p53-Carrying Cancer Cells 11
Totale 1.323
Categoria #
all - tutte 7.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 0 0 0 0 13 19 12 10
2020/2021100 14 1 14 4 5 18 6 1 11 4 0 22
2021/2022115 1 2 1 3 7 14 6 3 16 16 13 33
2022/2023326 23 61 21 41 20 57 15 22 41 0 19 6
2023/2024140 10 5 14 5 10 35 29 15 2 6 1 8
2024/2025288 38 82 47 15 6 64 10 22 4 0 0 0
Totale 1.323